Day Mark J. 4

4 · iRhythm Technologies, Inc. · Filed Feb 25, 2021

Form 4

Period: 2021-02-23

EVP, Research & Development

Transactions

Exercise/Conversion
Employee Stock Option (right to buy)
2021-02-23$63.95/sh+123$7,866→ 10,577 total
Exercise: $63.95From: 2019-03-01Exp: 2028-02-27→ Common Stock (123 underlying)
Exercise/Conversion
Common Stock
2021-02-23$17.00/sh+8,300$141,100→ 38,386 total
Exercise/Conversion
Common Stock
2021-02-23$63.95/sh+123$7,866→ 39,480 total
Exercise/Conversion
Employee Stock Option (right to buy)
2021-02-23$36.22/sh+971$35,170→ 14,077 total
Exercise: $36.22From: 2018-03-01Exp: 2027-02-08→ Common Stock (971 underlying)
Exercise/Conversion
Common Stock
2021-02-23$36.22/sh+971$35,170→ 39,357 total
Exercise/Conversion
Employee Stock Option (right to buy)
2021-02-23$17.00/sh+8,300$141,100→ 7,485 total
Exercise: $17.00From: 2017-09-21Exp: 2026-10-20→ Common Stock (8,300 underlying)

Footnotes (3)

[F1]The option, originally granted for 33,998 shares, of which 16,713 have been exercised, vested as to 25% of the shares on September 21, 2017, and as to 1/48 of the shares each month thereafter.
[F2]The option, originally granted for 23,300 shares, of which 8,252 have been exercised, vested as to 25% of the shares on March 1, 2018, and as to 1/48 of the shares each month thereafter.
[F3]The option vests as to 25% of the shares on March 1, 2019, and as to 1/48 of the shares each month thereafter.

Documents

1 file